<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02556970</url>
  </required_header>
  <id_info>
    <org_study_id>SU/2014/4744</org_study_id>
    <nct_id>NCT02556970</nct_id>
  </id_info>
  <brief_title>A Study Investigating Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgery</brief_title>
  <acronym>SiMuPort</acronym>
  <official_title>A Randomised Multi-centre Feasibility Study Investigating Post-operative Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgical (VATS) Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Bristol and Weston NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>David Telling Charitable Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospitals Bristol and Weston NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to establish if thoracoscopic surgery performed through a single port or&#xD;
      incision reduces early post-operative pain compared with conventional multiple port&#xD;
      thoracoscopic surgery.&#xD;
&#xD;
      This initial pilot study is designed to establish whether a trial of the two techniques is&#xD;
      acceptable to patients, clinically feasible and can be delivered in a reasonable timescale.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a patient- and assessor-blinded, multi-centre randomised trial with two groups (n=20&#xD;
      in each arm). Patients referred to Universities Hospital Bristol NHS Foundation Trust (n=20)&#xD;
      and Liverpool Heart and Chest Hospital NHS Foundation Trust (n=20) requiring elective VATS&#xD;
      lung surgery.&#xD;
&#xD;
      Patients will be identified and recruited by the thoracic surgeons in their surgical&#xD;
      outpatient clinic. Participants will receive verbal and written information about the two&#xD;
      different surgical techniques.&#xD;
&#xD;
      Consent will be sought by one of the surgical research nurses in the surgical outpatient&#xD;
      clinic after the thoracic surgeon has recruited them. On the rare occasion that this is not&#xD;
      possible, consent will occur in the pre-operative assessment clinic (POAC) at a later date.&#xD;
      All patients are seen in POAC at least 1 week prior to surgery except in extreme&#xD;
      circumstances. In POAC consent will also be sought by one of the surgical research nurses.&#xD;
&#xD;
      Participants will be given contact details for the study team should they have any questions&#xD;
      between consent and surgery. They will be able to withdraw consent at any time prior to&#xD;
      surgery.&#xD;
&#xD;
      All data will be entered into a Trust-based computer that is password protected. Subject&#xD;
      names will be kept on a database and will be linked only with a study identification number&#xD;
      for this research. There will be no patient identifiers. Only the research team will have&#xD;
      access to this computer. Data will be stored in a locked office and maintained for a minimum&#xD;
      of five years after the completion of the study.&#xD;
&#xD;
      Participants will be block randomised 1:1 in blocks of 10 between single port surgery and&#xD;
      multiple port surgery. Randomisation will occur by computer generation in theatre after&#xD;
      induction of anaesthesia using the website www.sealedenvelope.com.&#xD;
&#xD;
      The treatment arm will involve performance of the planned surgical procedure through a single&#xD;
      incision in the chest wall, without rib spreading. The camera and instruments will be placed&#xD;
      through this single incision. Use of a soft tissue retractor is permitted.&#xD;
&#xD;
      The control arm will undergo the operation through a standard 3-incision approach, again&#xD;
      without rib spreading.&#xD;
&#xD;
      All patients will receive skin dressings matching those for the multi-port technique,&#xD;
      irrespective of randomised allocation. Patients will be informed not to remove these&#xD;
      dressings for the first 24 hours. Surgical and anaesthetic staff members will be informed not&#xD;
      to communicate information about the treatment allocation to the patient or nursing staff.&#xD;
      The patient and the nursing staff undertaking pain assessments will not be aware of group&#xD;
      allocation for the first 24 hours. The research nurses collecting the data will also be&#xD;
      blinded.&#xD;
&#xD;
      The anaesthetic and surgical team involved cannot practically be blinded but will not be&#xD;
      involved in outcome data collection.&#xD;
&#xD;
      All patients will receive simple intra-operative analgesia in the form of 1g intravenous&#xD;
      paracetamol and 75mg intravenous diclofenac unless the patient is over 70 or has abnormal&#xD;
      renal function. Extra opioid analgesia will be given as intravenous fentanyl or morphine and&#xD;
      this will be titrated by the anaesthetist. The amount given will be documented as part of the&#xD;
      trial data.&#xD;
&#xD;
      At the end of the procedure, multiple level (target at least 4) intercostal blocks will be&#xD;
      placed subpleurally under thoracoscopic visualisation. 2ml of 2.5mg/ml Chirocaine&#xD;
      (Levobupivicaine hydrochloride) will be injected into each space.&#xD;
&#xD;
      Post-operative analgesia will compromise of 1g paracetamol four times a day for the first 3&#xD;
      days after surgery. Patient will receive IV morphine titrated to pain in recovery and&#xD;
      oramorph when they return to the ward. If patient is in significant pain a morphine patient&#xD;
      controlled analgesia (PCA) will be set up in recovery and for the first night after surgery&#xD;
      (1mg bolus, lockout 5mins). This will normally be discontinued on the first morning after&#xD;
      surgery.&#xD;
&#xD;
      The following data will be recorded for all patients enrolled in the study:&#xD;
&#xD;
      Pre-operatively:&#xD;
&#xD;
      â€¢ At consent, a baseline quality of life score will be recorded.&#xD;
&#xD;
      Intra-operatively:&#xD;
&#xD;
      The following times will be recorded on a sticker attached to the patient's anaesthetic&#xD;
      chart:&#xD;
&#xD;
        -  Time of induction of anaesthesia&#xD;
&#xD;
        -  Time of knife to skin&#xD;
&#xD;
        -  Time of skin closure&#xD;
&#xD;
        -  Time of extubation&#xD;
&#xD;
        -  Time arrived in recovery These times will be recorded by the research nurses allowing&#xD;
           the total surgical time (induction to skin closure) and total operative time (knife to&#xD;
           skin to skin closure) to be calculated.&#xD;
&#xD;
      Post-operative period (expected to be 36-48 hours post-surgery):&#xD;
&#xD;
        -  Visual Analogue Scale (VAS) pain scores are routinely recorded by the recovery nurses&#xD;
           and ward nurses every hour for the first 24 hours post operatively and subsequently&#xD;
           every 4 hours until discharge. So assuming the time into recovery is time zero the&#xD;
           investigators will collect a pain score at time zero and then every hour for the first&#xD;
           24 hours. The investigators will then collect a pain score every 4 hours until&#xD;
           discharge.&#xD;
&#xD;
        -  Patient satisfaction survey will be conducted on day 1 and day 2 post-op.&#xD;
&#xD;
        -  Total morphine consumption prior to discharge will be recorded.&#xD;
&#xD;
        -  Time of discharge.&#xD;
&#xD;
        -  Length of time chest drain remains in situ.&#xD;
&#xD;
        -  Volume of blood loss in chest drain in first 24 hours.&#xD;
&#xD;
      At 30 days:&#xD;
&#xD;
        -  All patients will complete a telephone quality of life score.&#xD;
&#xD;
        -  Serious adverse events recorded in first 30 days:&#xD;
&#xD;
             -  Death&#xD;
&#xD;
             -  Readmission to hospital&#xD;
&#xD;
             -  Re-operation&#xD;
&#xD;
             -  Admission to ICU&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study never started and was abandoned.&#xD;
  </why_stopped>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ability to randomise 40 patients into trial</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Median postoperative Visual Analogue Scale (VAS) pain score</measure>
    <time_frame>Before discharge (24-48 hours)</time_frame>
    <description>VAS pain score; 0 = no pain, 10 = worst pain participant could imagine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum post operative Visual Analogue Scale (VAS) pain score</measure>
    <time_frame>Before discharge (24-48 hours)</time_frame>
    <description>VAS pain score; 0 = no pain, 10 = worst pain participant could imagine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Visual Analogue Scale (VAS) pain score at 1 hour</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>VAS pain score; 0 = no pain, 10 = worst pain participant could imagine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Visual Analogue Scale (VAS) pain score at 24 hours</measure>
    <time_frame>At 24 hours after surgery</time_frame>
    <description>VAS pain score; 0 = no pain, 10 = worst pain participant could imagine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Crossover after randomisation</measure>
    <time_frame>During surgery (normal surgical time is approximately 1 hour)</time_frame>
    <description>Proportion of the trial (single port) arm converted to multiple port thoracoscopic or open approaches after randomisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total post-operative morphine consumption (mg)</measure>
    <time_frame>In the first 24 hours post-surgery</time_frame>
    <description>Total morphine dose in milligrams</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unexpected ICU admission</measure>
    <time_frame>After surgery and before discharge (expected to be with in 48 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital readmission rate</measure>
    <time_frame>Within 30 days of surgery</time_frame>
    <description>Readmission for any complication of the thoracic surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>Within 30 days of surgery</time_frame>
    <description>Diagnosed infection in or around the surgical incisions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life score</measure>
    <time_frame>Performed pre-operatively and at 30 days after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Single-port surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After induction of anaesthesia and lung isolation, a single intercostal incision will be placed laterally. This will usually be anterior to the border of the latissimus dorsi muscle, and in the 4th-7th space as appropriate to the planned surgery.&#xD;
A soft tissue wound protector can be used to protect the wound edges, but rigid intercostal retraction is not permitted. All instruments will be placed via this incision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple port surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will have 3 separate incisions placed to site the camera and other instruments. This will involve three separate incisions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single port VATS</intervention_name>
    <description>Performing video-assisted thorascopic surgery through a single port</description>
    <arm_group_label>Single-port surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>1g intraoperatively</description>
    <arm_group_label>Multiple port surgery</arm_group_label>
    <arm_group_label>Single-port surgery</arm_group_label>
    <other_name>Acetaminophen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <description>75mg intraoperatively</description>
    <arm_group_label>Multiple port surgery</arm_group_label>
    <arm_group_label>Single-port surgery</arm_group_label>
    <other_name>Voltarol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Camera (5mm diameter 30 degree videothoracoscope)</intervention_name>
    <arm_group_label>Multiple port surgery</arm_group_label>
    <arm_group_label>Single-port surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Forceps grasper</intervention_name>
    <arm_group_label>Multiple port surgery</arm_group_label>
    <arm_group_label>Single-port surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.25% Levobupivicaine intercostal nerve block</intervention_name>
    <description>Multi-level intercostal blocks will be placed subpleurally under thorascopic visualisation.</description>
    <arm_group_label>Multiple port surgery</arm_group_label>
    <arm_group_label>Single-port surgery</arm_group_label>
    <other_name>0.25% Chirocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects will be recruited from patients requiring VATS for elective lung, lymph node&#xD;
             or mediastinal biopsies or wedge resections of pulmonary nodules.&#xD;
&#xD;
          -  Technically suitable for both single port or multiport approaches in the opinion of&#xD;
             the recruiting surgeon.&#xD;
&#xD;
          -  ASA 1,2 or 3.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or breastfeeding.&#xD;
&#xD;
          -  Patient refusal.&#xD;
&#xD;
          -  Emergency surgery.&#xD;
&#xD;
          -  Patient unable to provide consent or complete the follow up.&#xD;
&#xD;
          -  Patients who attend a chronic pain clinic on high doses of opiate drugs.&#xD;
&#xD;
          -  History of Anaphylaxis/allergy to local anaesthetic.&#xD;
&#xD;
          -  Lobectomy patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca A Leslie, BM BS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Bristol and Weston NHS Foundation Trust</affiliation>
  </overall_official>
  <verification_date>November 2016</verification_date>
  <study_first_submitted>September 4, 2015</study_first_submitted>
  <study_first_submitted_qc>September 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2015</study_first_posted>
  <last_update_submitted>November 14, 2016</last_update_submitted>
  <last_update_submitted_qc>November 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

